ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 302

$446K Total Retail Price of All Prescriptions

Rank: 24 out of 302

262 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 262 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
PRAVASTATIN SODIUM 279 256 1 17
AMLODIPINE BESYLATE 250 222 2 2
LISINOPRIL 228 205 3 1
LEVOTHYROXINE SODIUM 216 197 4 9
METOPROLOL TARTRATE 206 195 5 5
OMEPRAZOLE 195 176 6 7
FUROSEMIDE 165 150 7 4
ATORVASTATIN CALCIUM 159 138 8 10
CITALOPRAM HBR 157 151 9 30
PANTOPRAZOLE SODIUM 139 120 10 25
MIRTAZAPINE 114 111 11 38
SIMVASTATIN 110 96 12 3
TRAMADOL HCL 110 108 12 16
HYDRALAZINE HCL 102 99 14 48
CARVEDILOL 100 88 15 19
METOPROLOL SUCCINATE 97 96 16 6
JANTOVEN 95 95 17 71
JANUVIA 93 93 18 157
RANITIDINE HCL 72 67 19 33
LOSARTAN POTASSIUM 72 61 19 24
ATENOLOL 67 56 21 20
SPIRONOLACTONE 66 47 22 108
METFORMIN HCL ER 65 52 23 125
CRESTOR 64 59 24 34
ISOSORBIDE MONONITRATE ER 64 63 24 37
CLOPIDOGREL 61 60 26 23
AZITHROMYCIN 60 56 27 79
LOSARTAN-HYDROCHLOROTHIAZIDE 59 45 28 90
HYDROCHLOROTHIAZIDE 57 55 29 12
FAMOTIDINE 56 52 30 203
GLIMEPIRIDE 55 43 31 128
METFORMIN HCL 54 47 32 13
ALLOPURINOL 54 54 32 77
ALENDRONATE SODIUM 52 45 34 49
DIOVAN 50 49 35 60
ADVAIR DISKUS 50 35 35 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.